D-0942-2018 Class II Terminated

Recalled by Avella Of Deer Valley, Inc. Store 38 — Phoenix, AZ

FDA drug recall D-0942-2018 was initiated by Avella Of Deer Valley, Inc. Store 38 on Jun 12, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential leakage of bags. The recall status is terminated (terminated Jan 24, 2020). Affected quantity: 20 bags.

Recall Details

Product Type
Drugs
Report Date
Jul 25, 2018
Initiation Date
Jun 12, 2018
Termination Date
Jan 24, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 bags

Product Description

0.2% ROPivacaine, (Ropivacaine HCL PF, USP 500mg, 0.9% Sodium Chloride, USP QS 250 mL). Volume 250 mL. Single dose Cassette. For: Parkland Memorial Hospital. By: Advanced Pharma, 9225 Kirby Dr. Houston, TX 77054. Parkland Memorial Hospital NDC 15082-002-87

Reason for Recall

Lack of Assurance of Sterility: Potential leakage of bags.

Distribution Pattern

Nationwide in the USA

Code Information

Lot 5/14/18 0722 47-00287Y EXP 06/28/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0942-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.